insights_auto
Outlook: 41.2% bullish·5.9% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
$119.09
arrow_downward
-0.98%(-1.18) 1D
$119.09
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 17, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$119.95
High
$121.43
Low
$118.05
Mkt. cap
24.27B
Avg. vol.
1.76M
Volume
2.25M
P/E ratio
63.33
52-wk high
$132.58
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
Open
$119.95
High
$121.43
Low
$118.05
Mkt. cap
24.27B
Avg. vol.
1.76M
Volume
2.25M
P/E ratio
63.33
52-wk high
$132.58
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
News stories
From web sources and news partners
www.marketscreener.com
·
2 hours ago
Incyte Insider Sold Shares Worth $1,292,032, According to a Recent SEC Filing
Zacks
·
8 hours ago
INCY Wins European Commission Nod For Skin Disease Drug
Seeking Alpha
·
8 hours ago
Incyte wins EU nod for Povofortay in hidradenitis suppurativa
Yahoo Finance
·
9 hours ago
INCY Wins European Commission Nod For Skin Disease Drug
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorHealth Care
IndustryBiotechnology
Websiteincyte.com